2 unchanged sentences
Except as previously disclosed on a Current Report on Form 8-K (File No.
−Removed: 001-38886) that we filed with the SEC on June 21, 2021, we did not sell or issue any equity securities during the three months ended June 30, 2021 that were not registered under the Securities Act.
+Added: 001-38886) that we filed with the SEC on June 21, 2021, we did not sell or issue any equity securities during the three months ended September 30, 2021 that were not registered under the Securities Act.
Use of Proceeds from IPO of Common Stock
5 unchanged sentences
No offering expenses were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning 10% or more of any class of our equity securities or to any other affiliates.
−Removed: As of June 30, 2021, we used approximately $35.5 million of the net proceeds from the IPO to fund the development of Haduvio for the treatment of pruritus associated with prurigo nodularis, the treatment of chronic cough in patients with IPF and general corporate purposes.
+Added: As of September 30, 2021, we used approximately $43.5 million of the net proceeds from the IPO to fund the development of Haduvio for the treatment of pruritus associated with prurigo nodularis, the treatment of chronic cough in patients with IPF and general corporate purposes.
There has been no material change in our planned use of the net proceeds from the IPO as described in our final prospectus for the IPO filed with the SEC pursuant to Rule 424(b) under the Securities Act.
We have invested the net proceeds from the IPO in money market funds.
−Removed: Purchase Agreement, dated as of June 18, 2021, by and between the Registrant and Lincoln Park Capital Fund, LLC (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38886) filed with the SEC on June 21, 2021)
−Removed: Registration Rights Agreement, dated as of June 18, 2021, by and between the Registrant and Lincoln Park Capital Fund, LLC (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38886) filed with the SEC on June 21, 2021)
+Added: Form of Pre-Funded Warrant dated October 5, 2021 (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 1, 2021)
+Added: Form of 7-Year Common Stock Warrant dated October 5, 2021 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 1, 2021)
+Added: Form of 3.5-Year Common Stock Warrant dated October 5, 2021 (incorporated by reference to Exhibit 4.3 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 1, 2021)
+Added: Form of 7-Year Common Stock Warrant dated October 18, 2021 (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 19, 2021)
+Added: Form of 3.5-Year Common Stock Warrant dated October 18, 2021 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 19, 2021)
First Amendment to Loan and Security Agreement, dated July 6, 2021, by and between Silicon Valley Bank and the Registrant (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File No.
001-38886) filed with the SEC on July 7, 2021)
−Removed: First Amendment to Exclusive License Agreement, dated June 24, 2021, by and between Rutgers, The State University of New Jersey and the Registrant
−Removed: Offer Letter, dated June 17, 2021, by and between the Registrant and Lisa Delfini
−Removed: Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C.
+Added: Second Amendment to Loan and Security Agreement, dated August 13, 2021, by and between Silicon Valley Bank and the Registrant
+Added: Form of Securities Purchase Agreement dated September 30, 2021 (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 1, 2021)
+Added: Form of Registration Rights Agreement dated September 30, 2021 (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 1, 2021)
+Added: Form of Securities Purchase Agreement dated October 15, 2021 (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 19, 2021)
+Added: Form of Registration Rights Agreement dated October 15, 2021 (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38886) filed with the SEC on October 19, 2021)
+Added: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Executive Officer Pursuant to 18 U.S.C.
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Financial Officer Pursuant to 18 U.S.C.
+Added: Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
8 unchanged sentences
TREVI THERAPEUTICS, INC.
−Removed: August 12, 2021
+Added: November 10, 2021
/s/ Jennifer L.
1 unchanged sentence
(Principal Executive Officer)
−Removed: and Principal Financial Officer)
−Removed: /s/ Christopher Galletta
−Removed: Christopher Galletta
−Removed: Controller and Treasurer
−Removed: (Principal Accounting Officer)
+Added: /s/ Lisa Delfini
+Added: Chief Financial Officer
+Added: (Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.